Skip to main content
. 2020 Sep 3;12(9):845. doi: 10.3390/pharmaceutics12090845

Table 4.

Skin irritation index of the blank NLC formulation (blank F4) and the orobol-loaded NLC formulation (F4) at 30 min, 24 h, and 48 h after the topical application to human volunteers for 24 h.

Formulation 30 Min 24 H 48 H
not-treated 0 0 0
blank F4 0.0167 0.0167 0.0167
F4 0.0167 0.0167 0.0167